Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A

Haemophilia. 2011 Sep;17(5):e837-40. doi: 10.1111/j.1365-2516.2011.02577.x. Epub 2011 Jun 7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blood Coagulation Factor Inhibitors / immunology*
  • Child
  • Child, Preschool
  • Drug Combinations
  • Factor VIII / immunology*
  • Factor VIII / therapeutic use
  • Female
  • Hemophilia A / drug therapy
  • Hemophilia A / immunology*
  • Humans
  • Immune Tolerance / drug effects*
  • Infant
  • Male
  • Middle Aged
  • Young Adult
  • von Willebrand Factor / immunology*
  • von Willebrand Factor / therapeutic use

Substances

  • Blood Coagulation Factor Inhibitors
  • Drug Combinations
  • factor VIII, von Willebrand factor drug combination
  • von Willebrand Factor
  • Factor VIII